Interestingly, ascites of pancreatic cancer patients were included in the work of Demotte et al. proving in vitro that GCS-100 boosts IFN-γ secretion by CD8+ TILS, which exhibited significant cytotoxicity [88] (Table 1). The gene discussed is CD8A; the disease is pancreatic neoplasm.